Importance Mutations of the glucocerebrosidase gene,GBA1(OMIM606463), are the most
important risk factor for Parkinson disease (PD). In vitro and in vivo studies have reported that …

GBA variants carriers are at increased risk of Parkinson’s disease (PD) and Lewy body
dementia (LBD). The presence of pseudogene GBAP1 predisposes to structural variants, …

Objectives GBA1 mutations are a frequent risk factor for Parkinson disease (PD). The aim of
this study is to evaluate clinical features in a group of GBA1 mutation–positive individuals …

Objective Rapid eye movement sleep behavior disorder (RBD) is a prodromal synucleinopathy,
as >80% will eventually convert to overt synucleinopathy. We performed an in‐depth …

Background Mutations in GBA cause Gaucher disease when biallelic and are strong risk
factors for Parkinson's disease when heterozygous. GBA analysis is complicated by the nearby …

The GBA1 gene encodes the lysosomal enzyme glucocerebrosidase (GCase), which is
involved in sphingolipid metabolism. Biallelic variants in GBA1 cause Gaucher disease (GD), a …

Objective To study the role of GBA variants in the risk for isolated REM sleep behavior disorder
(iRBD) and conversion to overt neurodegeneration. Methods A total of 4,147 individuals …

Microglia are heterogenous cells characterized by distinct populations each contributing to
specific biological processes in the nervous system, including neuroprotection. To elucidate …

Mutations in GBA which are causative of Gaucher disease in their biallelic form, are the most
common genetic risk factor for Parkinson's disease (PD). The diagnosis of PD relies upon …

Background Biallelic pathogenic variants in GBA1 are the cause of Gaucher disease (GD)
type 1 (GD1), a lysosomal storage disorder resulting from deficient glucocerebrosidase. …